Table 3 Characteristics of both groups with Wilcoxon test being used for comparison of differences, * indicating statistical significance (p < 0.05).
Overall: (n: 54) | Group A: No/failed MT (n: 25) | Group B: Successful MT (n: 29) | p-value | |
|---|---|---|---|---|
Age, years, mean ± SD | 67.0 ± 13.1 | 74.0 ± 10.0 | 61.0 ± 12.0 | 0.0004* |
Male sex, n (%) | 37 (68.5) | 16 (64.0) | 21 (72.4) | 0.518 |
NIHSS, mean ± SD | 15.3 ± 6.8 | 17.1 ± 5.4 | 14.2 ± 7.3 | 0.2038 |
Thrombolysis, n (%) | 33 (61.1) | 10 (40.0) | 23 (79.3) | 0.035* |
Interval between initial and follow-up imaging, days, mean; SD | 2.6 ± 2.7 | 2.9 ± 2.7 | 2.4 ± 2.6 | 0.48 |
Follow-up imaging with MRI, n (%) | 39 (72.0) | 10 (40.0) | 29 (100.0) | <0.0001* |
FIV, ml, mean; SD | 48.4 ± 15.16 | 66.1 ± 68.1 | 36.5 ± 56.2 | 0.12 |